A detailed history of Birinyi Associates Inc transactions in Amgen Inc stock. As of the latest transaction made, Birinyi Associates Inc holds 3,827 shares of AMGN stock, worth $1.13 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
3,827
Previous 3,827 -0.0%
Holding current value
$1.13 Million
Previous $1.2 Million 3.18%
% of portfolio
0.36%
Previous 0.36%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023

SELL
$225.79 - $275.2 $338,685 - $412,800
-1,500 Reduced 28.16%
3,827 $925,000
Q2 2021

Aug 05, 2021

SELL
$233.58 - $259.14 $23,358 - $25,914
-100 Reduced 1.84%
5,327 $1.3 Million
Q2 2020

Aug 06, 2020

SELL
$197.81 - $242.74 $276,934 - $339,836
-1,400 Reduced 20.51%
5,427 $1.28 Million
Q1 2020

May 12, 2020

SELL
$182.24 - $241.7 $223,244 - $296,082
-1,225 Reduced 15.21%
6,827 $1.38 Million
Q4 2019

Feb 12, 2020

BUY
$189.21 - $243.2 $23,651 - $30,400
125 Added 1.58%
8,052 $1.94 Million
Q2 2017

Aug 08, 2017

BUY
N/A
7,927
7,927 $1.37 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Birinyi Associates Inc Portfolio

Follow Birinyi Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Birinyi Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Birinyi Associates Inc with notifications on news.